COPD Research Review, Issue 56

In this issue:

Risk factors for and prevalence of chronic airflow obstruction
Four distinct COPD comorbidity profiles
Association of low-value ICS with downstream healthcare utilisation and costs
Low-dose theophylline ± prednisone does not reduce AECOPD risk
Dual bronchodilator therapy as first-line therapy in COPD patients
Mepolizumab for eosinophil-associated COPD
Validation of the COPDPredict™ app
An inhaled PI3Kδ inhibitor improves recovery in patients with AECOPD
Severity of AECOPD and effectiveness of pulmonary rehabilitation
Inflammatory endotype-associated airway microbiome in COPD

Please login below to download this issue (PDF)

Subscribe